Role of EGF receptor tyrosine kinase activity in antiapoptotic effect of EGF on mouse hepatocytes

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 280, Issue 6 43-6, 2001, Pages

  Musallam, Lina ^a,b   Éthier, Chantal ^a   Haddad, Pierre S ^a,b   Bilodeau, Marc ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Apoptosis; Bcl xL; Fas; Inhibitors of receptor tyrosine kinases; Receptor autophosphorylation

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; FAS ANTIBODY; MESSENGER RNA; N [4 (3 BROMOANILINO) 6 QUINAZOLINYL]ACRYLAMIDE; PROTEIN BCL X;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; LIVER CELL; LIVER DISEASE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0034972809     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2001.280.6.g1360     Document Type: Article

References (69)

1. How distinct are the insulin and the insulin-like growth factor I signalling systems?
2. The proto-oncogene Bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis
3. Perforin, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL
4. Activation and regulation of the insulin receptor kinase
5. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death
6. 2+ and pH
7. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding
8. Two- and three- dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell lines
9. Interleukin-3 induced phosphorylation of BAD through the protein kinase AKT
10. Fas and other cell death signaling pathways
11. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins
12. Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis
13. Protective effect of EGF and other liver growth factors on Fas-induced apoptosis in mouse hepatocytes
14. EGF has the capacity to block Fas-induced apoptosis and to increase the expression of BCL-xl in mouse hepatocytes
15. Mutation of the platelet-derived growth factor receptor that causes a loss of ligand-induced conformational change, subtle changes in kinase activity, and impaired ability to stimulate DNA synthesis
16. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
17. Growth factors and mitogen-activated protein kinases
18. Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor
19. Wortmannin enhances activation of CPP32 (caspase-3) induced by TNF or anti-Fas
20. Apoptosis in liver disease
21. CD95-induced apoptosis in human liver disease
22. Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts
23. Ultrastructural study of monolayer hepatocytes in adult rat cultures in the presence of hydrocortisone hemisuccinate
24. Bcl-xl regulates the membrane potential and volume homeostasis of mitochondria
25. Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation
26. Signal transduction via platelet-derived growth factor receptors
27. Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues
28. The apoptosisnecrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death
29. A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis
30. EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain
31. Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases
32. Bax directly induces release of cytochrome c from isolated mitochondria
33. Macrophage colony-stimulating factor promotes cell survival through Akt/ protein kinase B
34. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
35. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor
36. BCL-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice
37. Tyrosine kinase inhibition: An approach to drug development
38. Reconstitution of human epidermal growth factor receptors and its deletion mutants in cultured hamster cells
39. Activation of Ras by receptor tyrosine kinases
40. Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro
41. BCL-2 blocks glucocorticoid but not Fas or activation induced apoptosis in a T cell hybridoma
42. Les caspases, les proteases à cystéine de l'apoptose: Un enjeu théapeutique pour demain?
43. A point mutation at the ATP-binding site of the EGF receptor abolishes signal transduction
44. Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hepatocytes
45. The Fas death factor
46. Apoptosis and alcoholic liver disease
47. Bim: A novel member of the Bcl-2 family that promotes apoptosis
48. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis
49. Dysregulation of apoptosis as a mechanism of liver disease: An overview
50. c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases
51. BCL-2 and the ICE family of apoptotic regulators: Making a connection
52. Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl) amino]pyrido[D]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor
53. Detection and analysis of proteins expressed from cloned genes
54. Mutational analysis of the epidermal growth factor-receptor kinase
55. Biological role of epidermal growth factor-receptor clustering
56. Prevention of hypoxia-induced cell death by BCL-2 and BCL-xl
57. EGF receptor signaling inhibits keratinocyte apoptosis: Evidence for mediation by BCL-xl
58. BCL-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis
59. Hepatitis B virus HBx protein sensitizes cells to apoptosis killing by tumor necrosis factor α
60. Cloning and functional analysis of BAG-1: A novel BCL-2 binding protein with anti-cell death activity
61. A "housekeeping" gene on the X chromosome encodes a protein similar to ubiquitin
62. Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium
63. Cyclic adenosine monophosphate-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes
64. A role for protein kinase B and caspase 9 in bile acid induced apoptosis in cultured rat hepatocytes
65. Life, death, and the pursuit of apoptosis
66. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview
67. Requirement for phosphatidylinositol 3-kinase in the prevention of apoptosis by nerve growth factor
68. Growth factor receptor tyrosine kinases
69. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-xl